Monitoring the safety of a smallpox vaccination program in the United States: Report of the joint Smallpox Vaccine Safety Working Group of the Advisory Committee on Immunization Practices and the Armed Forces Epidemiological Board

Clinical Infectious Diseases

Volumn 46, Issue SUPPL. 3, 2008, Pages

  Neff, John ^a,b   Modlin, John ^c   Birkhead, Guthrie S ^d   Poland, Gregory ^g   Robertson, Rose Marie ^h,l   Sepkowitz, Kent ^e   Yancy, Clyde ⁱ   Gardner, Pierce ^f   Gray, Gregory C ^m   Maurer, Toby ⁿ   Siegel, Jane ⁱ   Guerra, Fernando A ^j   Berger, Tim ⁿ   Flanders, W Dana ^o   Shope, Robert ^k  

^a SEATTLE CHILDREN S RESEARCH INSTITUTE   (United States)

^b UNIVERSITY OF WASHINGTON   (United States)

^c DARTMOUTH MEDICAL SCHOOL   (United States)

^d STATE UNIVERSITY OF NEW YORK   (United States)

^e MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^f STONY BROOK UNIVERSITY   (United States)

^g MAYO CLINIC   (United States)

^h AMERICAN HEART ASSOCIATION   (United States)

ⁱ UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^j San Antonio Metropolitan Health District   (United States)

^k UNIVERSITY OF TEXAS MEDICAL BRANCH   (United States)

^l VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

^m UNIVERSITY OF IOWA   (United States)

ⁿ UNIVERSITY OF CALIFORNIA   (United States)

^o EMORY UNIVERSITY   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

CIDOFOVIR; SMALLPOX VACCINE; VACCINIA ANTIBODY; DRYVAX VACCINE; UNCLASSIFIED DRUG;

ARMY; ARTHRALGIA; ARTICLE; BACKACHE; CLINICAL PRACTICE; CONGESTIVE CARDIOMYOPATHY; DISEASE COURSE; DISEASE SEVERITY; DRUG SAFETY; FATIGUE; FEVER; HEADACHE; HEART MUSCLE ISCHEMIA; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNIZATION; IMMUNOSUPPRESSIVE TREATMENT; INJECTION SITE PAIN; INOCULATION; MEDICAL EDUCATION; MYALGIA; MYOCARDITIS; PATIENT CARE; PATIENT MONITORING; PERICARDITIS; PRIORITY JOURNAL; PRURITUS; RISK ASSESSMENT; SCREENING TEST; SMALLPOX; STEVENS JOHNSON SYNDROME; SUPERINFECTION; SWELLING; TREATMENT RESPONSE; UNITED STATES; VACCINATION; VACCINIA; ADOLESCENT; ADULT; AGED; DRUG SURVEILLANCE PROGRAM; EVALUATION; FEMALE; GOVERNMENT; HEALTH CARE PERSONNEL; HEALTH SURVEY; MALE; MASS IMMUNIZATION; MIDDLE AGED; RETROSPECTIVE STUDY; SOLDIER; STANDARD;

ADOLESCENT; ADULT; ADVERSE DRUG REACTION REPORTING SYSTEMS; AGED; FEMALE; HEALTH PERSONNEL; HUMANS; MALE; MASS IMMUNIZATION; MIDDLE AGED; MILITARY PERSONNEL; MYOCARDITIS; PERICARDITIS; RETROSPECTIVE STUDIES; SENTINEL SURVEILLANCE; SMALLPOX VACCINE; UNITED STATES; UNITED STATES DEPT. OF HEALTH AND HUMAN SERVICES;

EID: 41649110509     PISSN: 10584838     EISSN: None     Source Type: Journal    
DOI: 10.1086/524749     Document Type: Article

References (76)

1. Committee on Smallpox Vaccination Program Implementation, Baciu A, Anason AP, Stratton K, Strom B, eds. The smallpox vaccination program: public health in an age of terrorism. Washington, D.C.: National Academies Press, 3 March 2005. Available at: http://www.nap.edu. Accessed 18 October 2005.
2. Grabenstein JD, Winkenwerder W Jr. US military smallpox vaccination program experience. JAMA 2003; 289:3278-82.
3. Casey CG, Iskander J, Roper MH, et al. Adverse events associated with smallpox vaccination in the United States, January-October 2003. JAMA 2005; 294:2734-43.
4. Centers for Disease Control and Prevention. Recommendations for using smallpox vaccine in a pre-event vaccination program: supplemental recommendations of the Advisory Committee on Immunization Practices (ACIP) and the Healthcare Infection Control Practices Advisory Committee (HICPAC). MMWR Recomm Rep 2003; 52(RR-7):1-16.
5. Cooney EL, Collier AC, Greenberg PD, et al. Safety of and immunological response to a recombinant vaccinia virus vaccine expressing HIV envelope glycoprotein. Lancet 1991; 337:567-72.
6. Graham BS, Belshe RB, Clements ML, et al. Vaccination of vaccinia-naive adults with human immunodeficiency virus type 1 gp160 recombinant vaccinia virus in a blinded, controlled, randomized clinical trial. The AIDS Vaccine Clinical Trials Network. J Infect Dis 1992; 166:244-52.
7. Zhou W, Pool V, Iskander JK, et al. Surveillance for safety after immunization: Vaccine Adverse Event Reporting System (VAERS) - United States, 1991-2001. MMWR Surveill Summ 2003; 52:1-24 (erratum: MMWR Morb Mortal Wkly Rep 2003; 52:113).
8. Varricchio F, Iskander J, DeStefano F, et al. Understanding vaccine safety information from the Vaccine Adverse Event Reporting System. Pediatr Infect Dis J 2004; 23:287-94.
9. Singleton JA, Lloyd JC, Mootrey GT, Salive ME, Chen RT, VAERS Working Group. An overview of the Vaccine Adverse Event Reported System (VAERS) as a surveillance system. Vaccine 1999; 17:2908-17.
10. Klevens RM, Kupronis BA, Lawton R, Joseph D, Richards C, HSVMS Team. Monitoring healthcare workers after smallpox vaccination: finds from the Hospital Smallpox Vaccination Monitoring System. Am J Infect Control 2005; 33:315-9.
11. Centers for Disease Control and Prevention. Notice to readers: National Smallpox Vaccine in Pregnancy Registry. MMWR 2003; 52:256.
12. Iskander J, McMahon AW, Ball R, Grabenstein JD, Braun M. Adverse events after smallpox vaccination in the United States: summary of reports to the Vaccine Adverse Event Reporting System (VAERS) [abstract 115]. Pharmacoepidemiol Drug Saf 2003; 12:S57.
13. Chapman LE, Iskander J, Chen RT, Advisory Committee on Immunization Practices and the Armed Forces Epidemiological Board joint Smallpox Vaccine Safety Working Group. A process for sentinel case review to assess causal relationships between smallpox vaccination and adverse outcomes, 2003-2004. Clin Infect Dis 2008; 46(Suppl 3):S271-93 (in this supplement).
14. Neff JM, Lane JM, Pert JH, Moore R, Millar JD, Henderson DA. Complications of smallpox vaccination. I. National survey in the United States, 1963. N Engl J Med 1967; 276:125-32.
15. Neff JM, Levine RH, Lane JM, et al. Complications of smallpox vaccination in the United States, 1963. II. Results obtained by four statewide surveys. Pediatrics 1967; 39:916-23.
16. Lane JM, Ruben FL, Neff JM, Millar JD. Complications of smallpox vaccination, 1968. N Engl J Med 1969; 281:1201-8.
17. Lane JM, Ruben FL, Neff JM, Millar JD. Complications of smallpox vaccination, 1968: results of ten statewide surveys. J Infect Dis 1970; 122:303-9.
18. Casey C, Vellozzi C, Mootrey GT, et al. Surveillance guidelines for smallpox vaccine (vaccinia) adverse reactions. MMWR Recomm Rep 2006; 55(RR-1):1-16.
19. Vellozzi C, Averhoff F, Lane JM, et al. Superinfection following smallpox vaccination (vaccinia), United States surveillance, January 2003 through January 2004. Clin Infect Dis 2004; 39:1660-6.
20. Fulginiti VA, Papier A, Lane JM, Neff JM, Henderson DA. Smallpox vaccination: a review, part II. Adverse events. Clin Infect Dis 2003;37: 251-71.
21. Chopra A, Drage LA, Hanson EM, Touchet NL. Stevens-Johnson syndrome after immunization with smallpox, anthrax, and tetanus vaccines. Mayo Clin Proc 2004; 79:1193-6.
22. Vellozzi C, Lane JM, Averhoff F, et al. Generalized vaccinia, progressive vaccinia and eczema vaccinatum are rare following smallpox (vaccinia) vaccination: United States surveillance, 2003. Clin Infect Dis 2005; 41:689-97.
23. Kelly CD, Egan C, Davis SW, et al. Laboratory confirmation of generalized vaccinia following smallpox vaccination. J Clin Microbiol 2004; 42:1373-5.
24. Neff JM, Lane JM, Fulginiti VA, Henderson DA. Contact vaccinia - transmission of vaccinia from smallpox vaccination. JAMA 2002; 288:1901-5.
25. Ryan M. Smallpox: National Smallpox Vaccine in Pregnancy Registry analysis. Presented at the Advisory Committee on Immunization Practices (ACIP) Meeting, June 2004.
26. Ventura SJ, Hamilton BE, Sutton PD. Revised birth and fertility rates for the United States, 2000 and 2001. Natl Vital Stat Rep 2003; 51:1-18.
27. Nybo Andersen AM, Wohlfahrt J, Christens P, Olsen J, Melbye M. Maternal age and fetal loss: population based register. BMJ 2000; 320:1708-12.
28. Saraiya M, Berg CJ, Shulman H, Green CA, Atrash HK. Estimates of the annual number of clinically recognized pregnancies in the United States, 1981-1991. Am J Epidemiol 1999; 149:1025-9.
29. Hammerslough CR. Estimating the probability of spontaneous abortion in the induced abortion and vice versa. Public Health Rep 1992; 107:269-77.
30. Wilcox AJ, Weinberg CR, O'Connor JF, et al. Incidence of early loss of pregnancy. N Engl J Med 1988; 319:189-94.
31. Ryan MAK, Seward JF. Pregnancy, birth, and infant health outcomes from the National Smallpox Vaccine in Pregnancy Registry, 2003-2006. Clin Infect Dis 2008; 46(Suppl 3):S221-6 (in this supplement).
32. Beckwith JB. Defining the sudden infant death syndrome. Arch Pediatr Adolesc Med 2003; 157:286-90.
33. Byard RW, Krous HF. Sudden infant death syndrome: overview and update. Pediatr Dev Pathol 2003; 6:112-27.
34. Tasker SA, Schnepf GA, Lim M, et al. Unintended smallpox vaccination of HIV-1 - infected individuals in the United States military. US Department of Defense Tri-Service AIDS Clinical Consortium. Clin Infect Dis 2004; 38:1320-2.
35. Barkdoll TW, Cabiad RB, Tankersley MS, et al. Secondary and tertiary transfer of vaccinia virus among U.S. military personnel - United States and worldwide, 2002-2004. MMWR Morb Mortal Wkly Rep 2004; 53:103-5.
36. Garde V, Harper D, Fairchok MP. Tertiary contact vaccinia in a breastfeeding infant. JAMA 2004; 291:725-7.
37. Sejvar JJ, LaButta RJ, Chapman LE, Grabenstein JD, Iskander J, Lane JM. Neurological adverse events associated with smallpox vaccination in the United States, 2002-2004. JAMA 2005; 294:2744-50.
38. Sejvar J, Boneva R, Lane JM, Iskander J. Severe headaches following smallpox vaccination. Headache 2005; 45:87-8.
39. Garg RK. Acute disseminated encephalomyelitis. Postgrad Med J 2003; 79:11-7.
40. McMahon AW, Bryant-Genevier MC, Woo EJ, Braun MM, Ball R. Photophobia following smallpox vaccination. Vaccine 2005; 23: 1097-8.
41. Feldman AM, McNamara D. Myocarditis. N Engl J Med 2000; 343: 1388-98.
42. Mason JW. Myocarditis and dilated cardiomyopathy: an inflammatory link. Cardiovasc Res 2003; 60:5-10.
43. Richardson P, McKenna W, Bristow M, et al. Report of the 1995 World Health Organization/International Society and Federation of Cardiology Task Force on the definition and classification of cardiomyopathies. Circulation 1996; 93:841-2.
44. Halsell JS, Riddle JR, Atwood JE, et al. Myo-pericarditis following smallpox vaccination among vaccinia-naive US military personnel. JAMA 2003; 289:3283-9.
45. Murphy JG, Wright RS, Bruce GK, et al. Eosinophilic-lymphocytic myocarditis after smallpox vaccination. Lancet 2003; 362:1378-80.
46. Saurina G, Shirazi S, Lane JM, Daniel B, DiEugenia L. Myocarditis after smallpox vaccination: a case report. Clin Infect Dis 2003; 37: 145-6.
47. Guerdan BR. Case report: a presumptive case of vaccinia myocarditis. Mil Med 2004; 169:866-7.
48. Arness MK, Eckart RE, Love SS, et al. Myo-pericarditis following smallpox vaccination. Am J Epidemiol 2004; 160:642-51.
49. Morgan J, Roper MH, Sperling L, et al. Myocarditis, pericarditis, and dilated cardiomyopathy after smallpox vaccination among civilians in the United States, January-October 2003. Clin Infect Dis 2008; 46(Suppl 3):S242-50 (in this supplement).
50. Sniadack MM, Neff LJ, Swerdlow DL, Schieber RA, McCauley MM, Mootrey GT. Follow-up of cardiovascular adverse events after smallpox vaccination among civilians in the United States, 2003. Clin Infect Dis 2008; 46(Suppl 3):S251-7 (in this supplement).
51. Cassimatis DC, Atwood JE, Engler RM, Linz PE, Grabenstein JD, Vernalis MN. Smallpox vaccination and myo-pericarditis: a clinical review. J Am Coll Cardiol 2004; 43:1503-10.
52. Eckart RE, Love SS, Atwood JE, et al. Incidence and follow-up of inflammatory cardiac complications following smallpox. J Am Coll Cardiol 2004; 44:201-5.
53. Swerdlow DL, Roper MH, Morgan J, et al. Ischemic cardiac events during the Department of Health and Human Services smallpox vaccination program, 2003. Clin Infect Dis 2008; 46(Suppl 3): S234-41 (in this supplement).
54. Centers for Disease Control and Prevention. Notice to readers: supplemental recommendations on adverse events following smallpox vaccination in the pre-event vaccination program: recommendations of the Advisory Committee on Immunization Practices. MMWR Morb Mortal Wkly Rep 2003; 52:282-4.
55. Hu G, Wang MJ, Miller MJ, et al. Ocular vaccinia following exposure to a smallpox vaccinee. Am J Ophthalmol 2004; 137:554-6.
56. Fillmore GL, Ward TP, Bower KS, et al. Ocular complications of the Department of Defense smallpox vaccination program. Ophthalmology 2004; 111:2086-93.
57. Redfield RR, Wright DC, James WD, Jones TS, Brown C, Burke DS. Disseminated vaccinia in a military recruit with human immunodeficiency virus (HIV) disease. N Engl J Med 1987; 316:673-6.
58. Bartlett JG. Smallpox vaccination and patients with human immunodeficiency virus infection or acquired immunodeficiency syndrome. Clin Infect Dis 2003; 36:468-71.
59. Wharton M, Strikas RA, Harpaz R, et al. Recommendations for using smallpox vaccine in a pre-event vaccination program: supplemental recommendations of the Advisory Committee on Immunization Practices (ACIP) and the Healthcare Infection Control Practices Advisory Committee (HICPAC). MMWR Recomm Rep 2003; 52(RR-7):1-16.
60. Centers for Disease Control and Prevention. Vaccinia (smallpox) vaccine: recommendations of the Advisory Committee on Immunization Practices (ACIP), 2001. MMWR Recomm Rep 2001; 50(RR-10):1-25.
61. DoD Smallpox Vaccination Program. Resource center: forms. Available at: http://www.smallpox.mil/resource/forms.asp. Accessed 25 January 2008.
62. Baggs J, Chen RT, Damon IK, et al. Safety profile of smallpox vaccine: insights from the laboratory worker smallpox vaccination program. Clin Infect Dis 2005; 40:1133-40.
63. Olmsted SS, Grabenstein JD, Jain AK, et al. Use of an electronic monitoring system for self- reporting smallpox vaccine reactions. Biosecur Bioterror 2005; 3:198-206.
64. Oh RC. Folliculitis after smallpox vaccination: a report of two cases. Mil Med 2005; 170:133-6.
65. Talbot TR, Bredenberg HK, Smith M, LaFleur BJ, Boyd A, Edwards KM. Focal and generalized folliculitis following smallpox vaccination among vaccinia-naive recipients. JAMA 2003; 289:3290-4.
66. Talbot TR, Ziel E, Doersam JK, LaFleur B, Tollefson S, Edwards KM. Risk of vaccinia transfer to the hands of vaccinated persons after smallpox immunization. Clin Infect Dis 2004; 38:536-41.
67. Hepburn MJ, Dooley DP, Murray CK, et al. Frequency of vaccinia virus isolation on semipermeable versus nonocclusive dressings covering smallpox vaccination sites in hospital personnel. Am J Infect Control 2004; 32:126-30.
68. + cytotoxic T-lymphocyte responses in primary vaccinees and revaccinees. Clin Diagn Lab Immunol 2004; 11:758-61.
69. Waibel KH, Ager EP, Topolski RL, Walsh DS. Randomized trial comparing vaccinia on the external surfaces of 3 conventional bandages applied to smallpox vaccination sites in primary vaccinees. Clin Infect Dis 2004; 39:1004-7.
70. Centers for Disease Control and Prevention. Women with smallpox vaccine exposure during pregnancy reported to the National Smallpox Vaccine in Pregnancy Registry - United States, 2003. MMWR Morb Mortal Wkly Rep 2003; 52:386-8.
71. Acambis. Myocarditis cases in ACAM2000 trial. Available at: http://www.acambis.co.uk/default.asp?idp1189. Accessed 25 January 2008.
72. Fairweather D, Kaya Z, Shellam GR, Lawson CM, Rose NR. From infection to autoimmunity. J Autoimmun 2001; 16:175-86.
73. Kurrer MO, Kopf M, Penninger JM, Eriksson U. Cytokines that regulate autoimmune myocarditis. Swiss Med Wkly 2002; 132: 408-13.
74. Penninger JM, Bachmaier K. Review of microbial infections and the immune response to cardiac antigens. J Infect Dis 2000; 181: S498-504.
75. Eriksson U, Ricci R, Hunziker L, et al. Dendritic cell-induced autoimmune heart failure requires cooperation between adaptive and innate immunity. Nat Med 2003; 9:1484-90.
76. Rubin DR, Hendy V. Swine influenza and the news media. Ann Intern Med 1977; 87:769-74.